DLA Piper advised Iovance Biotherapeutics, Latham & Watkins advised the underwriters on the transaction. Iovance Biotherapeutics, Inc. (Iovance), a biotechnology company focused on innovating, developing and...
You must be a Standard 1 Year member to access this content.
DLA Piper advised BVP Forge on the transaction. Radformation, a leader in cancer care clinical and operational software solutions, announced that BVP Forge has made a...
You must be a Standard 1 Year member to access this content.
DLA Piper advised BVP Forge in the transaction. BVP Forge executed an investment in Parsec Automation Corp (Parsec), a Manufacturing Operations Management (MOM) software company. BVP...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Axsome Therapeutics on the offering. Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
You must be a Standard 1 Year member to access this content.
